Alnylam Pharmaceuticals | ALNY - Passifs Courants

Prix De L'Action
315.90
Variation Quotidienne
14.71 4.88%
Mensuellement
-4.52%
Annuel
23.82%
Q2 Prévisions
299.00




Passifs Courants Changement Date
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Incyte USD 1.49B 25.52M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 27.28B 4.72B 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 9.32B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xencor USD 95.91M 9.42M 2025-12